Pergolide improvement in neuroleptic-resistant Tourette cases: Various mechanisms causing tics

Neurological Sciences

Volumn 26, Issue 2, 2005, Pages 137-139

  Cianchetti, C ^a   Fratta, A ^a   Pisano, T ^a   Minafra, L ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

D1 receptors; D2 receptors; GABAergic neurons; Pergolide; Tics; Tourette

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; APOMORPHINE; CLONIDINE; DOMPERIDONE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; PERGOLIDE; PIMOZIDE; RISPERIDONE;

ARM MUSCLE; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CHILD; CLINICAL FEATURE; CLINICAL OBSERVATION; COMORBIDITY; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; FEMALE; FOLLOW UP; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; MEDICAL ASSESSMENT; MYOCLONUS; PRESYNAPTIC INHIBITION; SIDE EFFECT; TIC;

ANTIPARKINSON AGENTS; ANTIPSYCHOTIC AGENTS; CHILD; FEMALE; HUMANS; MALE; PERGOLIDE; TICS; TOURETTE SYNDROME;

EID: 22144491165     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-005-0448-z     Document Type: Article

References (10)

1. Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR (2000) Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial. Neurology 54:1310-1315
2. Gilbert DL, Dure L, Sethuraman G, Raab D, Lane J, Sallee FR (2003) Tic reduction with pergolide in a randomized cotrolled trial in children. Neurology 60:606-611
3. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KI, Stevenson J, Cohen DJ (1989) The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28:566-573
4. Lehmann J, Briley M, Langer SZ (1983) Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists. Eur J Pharmacol 88:11-26
5. Lin JY, Dubey R, Funk GD, Lipski J (2003) Receptor subtype-specific modulation by dopamine of glutamatergic responses in striatal medium spiny neurons. Brain Res 959:251-262
6. Piggott MA, Marshall EF, Thomas N, Lloyd S, Curt JA, Jaros E, Costa D, Perry RH, Perry EK (1999) Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine. Neuroscience 90:433-445
7. Gorelova N, Seamans JK, Yang CY (2002) Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. J Neurophysiol 88:3150-3166
8. Hernàndez-Lopez S, Tkatch T, Perez-Garci E, Galarraga E, Bargas J, Hamm H, Surmeier DJ (2000) D2 dopamine receptors in striatal medium spiny neurons reduce L-Type Ca2+ currents and excitability via a novel PLCb1-IP3-calcineurin-signaling cascade. J Neurosci 20:8987-8995
9. Black KJ, Mink JW (2000) Response to levodopa challenge in Tourette syndrome. Mov Disord 15:1194-1198
10. Nomura Y, Segawa M (2003) Neurology of Tourette's syndrome (TS). TS as a developmental dopamine disorder: A hypothesis. Brain Dev 25[Suppl 1]:S37-S42